GD
42
4
NEM
30
2
PNC
48
6
XOM
33
3
CMA
42
3
GT
43
2
HAS
29
3
FE
34
4
CTAS
36
8
AIZ
61
5
JPM
59
6
ADBE
50
3
PHM
44
4
T
32
2
CCL
68
6
LEG
16
2
NWL
48
4
AES
47
4
NDAQ
46
2
ED
39
8
GD
42
4
NEM
30
2
PNC
48
6
XOM
33
3
CMA
42
3
GT
43
2
HAS
29
3
FE
34
4
CTAS
36
8
AIZ
61
5
JPM
59
6
ADBE
50
3
PHM
44
4
T
32
2
CCL
68
6
LEG
16
2
NWL
48
4
AES
47
4
NDAQ
46
2
ED
39
8
Financhill
Back

Neinor Homes SA 10K Form

Sell
35

NNRHF
Neinor Homes SA

Last Price:
$12.75
Seasonality Move:
2.47%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NNRHF News And Ratings

See the #1 stock for the next 7 days that we like better than NNRHF

NNRHF Financial Statistics

Sales & Book Value

Annual Sales: $639.4M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $13.58
Price / Book: 0.94

Profitability

EPS (TTM): 1.38490
Net Income (TTM): $103.3M
Gross Margin: $198.2M
Return on Equity: 9.94%
Return on Assets: 5.67%

Neinor Homes SA Earnings Forecast

Key Neinor Homes SA Financial Ratios

  • The Gross Profit Margin over the past 9 years for NNRHF is 31.00%.
  • The Selling, General & Administrative Expenses for NNRHF have been equal to 0.53% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 28.38% of Operating Income.
  • The Net Earning history of NNRHF is 15.34% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 5 years.

Neinor Homes SA Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Household Durables
Sector: Consumer Discretionary
Current Symbol: NNRHF
Website: neinorhomes.com

Debt

Debt-to-Equity Ratio: 0.42
Current Ratio: 2.9
Quick Ratio: 0.67

Price-to-Earnings

Trailing P/E Ratio: 9.69
Forward P/E Ratio: 0

NNRHF Technical Analysis vs Fundamental Analysis

Sell
35
Neinor Homes SA (NNRHF) is a Sell

Is Neinor Homes SA a Buy or a Sell?

  • Neinor Homes SA stock is rated a Sell
    The current Neinor Homes SA [NNRHF] share price is $12.75. The Score for NNRHF is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.